Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Clin Transl Oncol ; 17(11): 870-5, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26055340

ABSTRACT

BACKGROUNDS: The present study aimed to evaluate benefit of hepatic arterial infusion chemotherapy (HAI) combined with systemic chemotherapy (SCT) for patients with colorectal liver metastases (CLMs) in a palliative setting. METHODS: This was a retrospective single-center study including 43 consecutive patients with CLM after failure of standard SCT. Among them, 20 (47 %) patients underwent HAI combined with SCT (Group A) and 23 historical control patients who had received SCT with or without targeted agent treatment (Group B). RESULTS: The two groups had similar characteristics. Compared with SCT alone, HAI combined with SCT prolonged survival (median 19.8 vs. 9.0 months; P = 0.045). Median hepatic progression-free survival was significantly longer for HAI combined with SCT vs. SCT alone (median 8.1 vs. 4.7 months; P = 0.027), as were response rates (25 and 0 %; P = 0.038) and progression-free survival (median 5.7 vs. 3.0 months; P = 0.02). Three patients (15 %) achieved conversion to potentially curative surgery. Grade 3/4 toxicities for Group A and Group B were neutropenia (5 and 8.7 %, respectively), anemia (5 and 0 %, respectively), and hyperbilirubinemia (0 and 4.3 %, respectively). Other complications were mostly grade 1 or 2. CONCLUSIONS: HAI combined with SCT treatment can improve overall survival compared with SCT alone in highly advanced CLM refractory to intravenous chemotherapy.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Agents/administration & dosage , Colorectal Neoplasms/drug therapy , Liver Neoplasms/drug therapy , Salvage Therapy/methods , Adenocarcinoma/mortality , Adenocarcinoma/secondary , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/adverse effects , Colorectal Neoplasms/mortality , Colorectal Neoplasms/pathology , Disease-Free Survival , Female , Hepatic Artery , Humans , Infusions, Intra-Arterial , Kaplan-Meier Estimate , Liver Neoplasms/mortality , Liver Neoplasms/secondary , Male , Middle Aged , Retrospective Studies
2.
Genet Mol Res ; 12(4): 6860-70, 2013 Dec 19.
Article in English | MEDLINE | ID: mdl-24391034

ABSTRACT

A drought-induced gene, DIP3, encoding a chitinase III protein was isolated from the roots of upland rice by reverse transcription-polymerase chain reaction (RT-PCR). Sequence analysis demonstrated that the cDNA and deduced protein showed high identity to Oryza sativa class III chitinase. The deduced protein contained a signal peptide sequence in the N-terminal region of 21aa and a conserved glycosyl hydrolase (GH) 18 domain. The secondary and 3D structures were analyzed and showed that it contained α-helix, ß-sheets, extended strand and random coil structures and that it was approximately spheroidal. Real-time quantitative PCR analysis revealed that expression levels accumulated rapidly under different forms of abiotic stress (drought, salt and low temperature), peaked at different times and then decreased. These results implied that as a member of class III chitinases, DIP3 may function as a stress-induced protein involved in the regulation of plant stress response.


Subject(s)
Chitinases/genetics , Oryza/genetics , Stress, Physiological/genetics , Amino Acid Sequence , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , DNA, Plant/genetics , Droughts , Gene Expression Regulation, Plant , Molecular Sequence Data , Plant Proteins/genetics , Protein Structure, Tertiary , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Analysis, DNA , Sequence Homology, Amino Acid
3.
J Anim Physiol Anim Nutr (Berl) ; 93(2): 271-6, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18492030

ABSTRACT

The effects of supplementing a barley-based diet for weaned piglets withexogenous beta-glucanase and xylanase on gastrointestinal digestiveenzyme activities were investigated. Thirty-six cross-bred weaned pigletswere randomly assigned to two groups with three pens based on sexand mass. Each group was fed on the diet based on barley with or withoutadded beta-glucanase and xylanase (0.15%) for a 4-week period. Theresults showed that enzyme supplementation improved growth performanceof piglets significantly (p < 0.05), but had no effect (p = 0.091)on average daily feed intake. The results also showed that supplementationof beta-glucanase and xylanase had no effect on pepsin activity in gastriccontents but slightly decreased (p = 0.092) the pepsin activity ingastric mucosa. Meanwhile, no effect of enzyme supplementation ontrypsin activity in duodenal contents was observed. However, the activitiesof amylase and lipase in duodenal contents were significantly(p < 0.05) decreased, whereas the activities of maltase, sucrase andgamma-glutamyl transpeptidase (gamma-GT) in jejunal and ileal mucosa wereenhanced significantly (p < 0.05). The improvement of disaccharidaseand gamma-GT activity may be attributed to the positive impacts of exogenousenzymes on digestion and absorption of the nutrients. In conclusion,the current results indicated that supplementation with enzymes in barley-based diets could improve the growth performance of piglets,decrease the activities of amylase and lipase in duodenal contents andincrease the activities of disaccharidase and gamma-GT in jejunal and ilealmucosa.


Subject(s)
Digestion/physiology , Endo-1,4-beta Xylanases/pharmacology , Gastrointestinal Tract/enzymology , Glycoside Hydrolases/pharmacology , Hordeum/chemistry , Swine/physiology , Animal Feed/analysis , Animal Nutritional Physiological Phenomena , Animals , Diet/veterinary , Dietary Supplements , Enzymes/metabolism , Weaning
4.
Cancer Immunol Immunother ; 38(3): 208-13, 1994 Mar.
Article in English | MEDLINE | ID: mdl-8124690

ABSTRACT

A selection of 16 monoclonal antibodies has been produced against a fresh Ewing's sarcoma (ES) tumor mixed with a permanent ES cell line. The majority of antibodies identify an 80-kDa molecule, which is not detected on healthy tissues except on certain cultured monocytes. One antibody recognizes the CD2 ligand MIC2 and 2 antibodies (numbers 13 and 16) define a higher-molecular-mass antigen. Antibody 16 is also expressed on mesenchymal fibroblasts of bone marrow or fetal origin. Tumor-specific antigen expression is potentially linked to the chromosome 22 abnormality described in Ewing's sarcoma, products altered expression in tumors with the chromosome 11/22 translocation has not been shown. The putative chimeric protein on chromosome 11 is apparently not expressed to a great extent, as tested by Northern blotting; however, the fusion protein initiated on chromosome 22 and ending on chromosome 11 is readily seen on Northern blots. The altered expression of a number of cellular genes in addition to a novel gene product(s) originating from translocation events were expected to be identified by monoclonal antibodies selected by their unique binding pattern to Ewing's sarcoma (ES) cells.


Subject(s)
Antibodies, Monoclonal/immunology , Antibodies, Neoplasm/immunology , Sarcoma, Ewing/immunology , Animals , Antibody Specificity , Antigens, Neoplasm/immunology , Antigens, Surface/immunology , Flow Cytometry , Immunoglobulin Isotypes/immunology , Immunohistochemistry , Mice , Mice, Inbred BALB C
5.
J Tongji Med Univ ; 10(1): 15-8, 1990.
Article in English | MEDLINE | ID: mdl-2348483

ABSTRACT

Pokeweed antiviral protein (PAP-s) was prepared from seeds of Phytolacca americana. Monoclonal antibody against human pan-T lymphocyte Wu71 was linked to PAP-s by a disulfide bond. The results of SDS-PAGE, double immunodiffusion of active monoclonal antibody and PAP-s showed that the conjugate was highly cytotoxic to the human T-leukemic cell line CEM, but not to antigen-negative cell line SP2/O. At a concentration of 10(-9) mol/L, 76.4% of the target cells were killed, as compared with 10.1% at 10(-9) mol/L of free PAP-s. Treatment of the CEM cells with conjugate at 10(-9) mol/L reduced their rate of protein synthesis by 72.4%, as determined with 14C-leucine incorporation. The immunotoxin may be useful for the in-vitro eradication of leukemic cells in autologous bone marrow transplantation to leukemia patients.


Subject(s)
Antineoplastic Agents, Phytogenic , Immunotoxins/pharmacology , Leukemia, T-Cell/pathology , N-Glycosyl Hydrolases , Plant Proteins/pharmacology , Antibodies, Monoclonal/pharmacology , Antibodies, Neoplasm/pharmacology , Cytotoxicity, Immunologic/drug effects , Humans , Leukemia, T-Cell/immunology , Ribosome Inactivating Proteins, Type 1 , T-Lymphocytes/immunology , Tumor Cells, Cultured/drug effects
6.
Transplantation ; 44(2): 295-302, 1987 Aug.
Article in English | MEDLINE | ID: mdl-2957831

ABSTRACT

The specificity of a novel monoclonal antibody (moAB), TU69, directed to the interleukin 2 receptor (IL-2R) was verified by sequential immunoprecipitation with anti-Tac. TU69 cross-competed with anti-Tac in binding analyses. When TU69 was added during the sensitization of normal peripheral blood mononuclear cells (PBMC) to allogeneic HLA-class I or -class II mismatched stimulator PBMC, alloproliferative responses and specific cytotoxicity were no longer detectable and the generation of natural killer (NK)-like effector cells was partially inhibited. Remarkably, however, the generation of CD4+ nonspecific suppressor T cells in such mixed lymphocyte cultures (MLC) was not inhibited--but, in contrast, was strongly enhanced in the presence of TU69. These suppressor cells inhibited unrelated allospecific responses in vitro to background levels even at a ratio of 50:1 responder:irradiated suppressor T cell lines. Such a potent experimental suppressor system suggests a possible application of TU69 for in vivo tolerance induction after transplantation, by down-regulating allospecific effector cells and allowing the generation of tolerance to graft antigens.


Subject(s)
Antigens, Surface/analysis , Immune Tolerance , Receptors, Immunologic/immunology , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes/immunology , Antibodies, Monoclonal/immunology , Antigens, Differentiation, T-Lymphocyte , Clone Cells/immunology , Humans , Lymphocyte Activation , Lymphocyte Culture Test, Mixed , Receptors, Interleukin-2 , T-Lymphocytes/classification
SELECTION OF CITATIONS
SEARCH DETAIL
...